Advertisement
open access | | logout
Medical Conferences

Medical Conferences

  • Conference Reports
  • Conference Proceedings
  • Specialties
    • Cardiology
    • Dermatology
    • Endocrinology
    • Gastroenterology
    • Haematology
    • Nephrology
    • Neurology
    • Oncology
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Urology
  • Multimedia
    • Podcast channel
    • Video channel
  • About
    • 2025 Medicom Conference Planning
    • About Conference Proceedings
    • Webinar
Home > Pulmonology > ATS 2021

ATS 2021


American Thoracic Society 14–19 May 2021
  • Table of Contents
  • Colophon

Table of Contents



Featured articles

Letter from the Editor

Editor
Prof. Richard Dekhuijzen, Radboud University Medical Center, the Netherlands

Interview with Past President Prof. Juan C. Celedón

Expert
Prof. Juan C. Celedón

ATS 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom

COVID-19: What Pulmonologists Need to Know

Antibody treatment for COVID-19: a combination is successful

Presented By
Dr Julie V. Philley, University of Texas Health Science Center, USA

Air pollution: an underestimated negative prognostic factor for COVID-19

Presented By
Prof. Meredith McCormack, John Hopkins University, MD, USA

Healthcare workers vulnerable to SARS-CoV-2 infections

Presented By
Prof. Reynold A. Panettieri Jr, Rutgers Institute for Translational Medicine and Science, NJ, USA

Genetic risk variants responsible for COVID-19 predisposition

Presented By
Dr Ana Hernandez Cordero, Centre for Heart Lung Innovation, University of British Columbia, Canada

Asthma – An Update

“As-needed” inhaled corticosteroid therapy for mild asthma – what is the evidence?

Presented By
Prof. Kaharu Sumino, Prof. Anne Dixon

IL-4/13 blocker successful in treatment of paediatric moderate-to-severe asthma

Presented By
Prof. Leonhard B. Bacharier, Vanderbilt University Medical Center, TN, USA

Benralizumab lives up to its phase 3 results in real-world findings

Presented By
Dr Donna Carstens, AstraZeneca, Wilmington, DE, USA

Tezepelumab – good success rates in various types of severe asthma

Presented By
Prof. Michael E. Wechsler, National Jewish Health, Denver, CO, USA

Sleep Disorders – An Underestimated Problem

OSA: A risk factor for earlier cognitive decline

Presented By
Prof. Andrew W. Varga, Mount Sinai Integrative Sleep Center, NY, USA

Subgroup of patients with high heart rate response and coronary artery disease benefit from CPAP

Presented By
Prof. Ali Azarbarzin, Harvard Medical School, MA, USA

Association between positive airway pressure treatment adherence and COVID-19 infection rates

Presented By
Dr Dennis Hwang, Kaiser Permanente, CA, USA

COPD – What Is New

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By
Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA

Does COPD plus COVID-19 equal higher mortality?

Presented By
Dr Jacob Schwartz, Lenox Hill Hospital, NY, USA

Biomarkers for acute exacerbations in COPD are required

Presented By
Prof. Don D. Sin, University of British Columbia, BC, Canada

Severe exacerbations: A key driver of all-cause mortality in COPD patients

Presented By
Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, NY, USA

Men and women with COPD differ in many ways

Presented By
Dr Franziska Trudzinski, University Hospital Centre Heidelberg, Germany

Younger adults with COPD at higher health risk than previously thought

Presented By
Dr Alina J. Blazer, University of Toronto, ON, Canada

Metabolic Dysregulation and Lung Disease

Obesity: A risk factor for new-onset asthma and worse asthma control

Presented By
Prof. Fernando Holguin, University of Colorado Asthma Research and Education, CO, USA

Metabolic dysfunction and lung disease: children are no small adults

Presented By
Prof. Erick Forno, University of Pittsburgh, PA, USA

Best of the Posters

Air pollution in winter linked to more hospital admissions in ILD patients

Presented By
Dr Marya Ghazipura, Marron Institute of Urban Management, NY, USA

Tobacco biomarkers do not improve prediction of lung cancer risk

Presented By
Dr Christine Lambert, University of Minnesota, USA

Vaping identified as risk factor for asthma

Presented By
Prof. Theresa To, The Hospital for Sick Children, ON, Canada

Advanced cystic fibrosis – improved lung function with long-term triple therapy

IPF patients benefit from early antifibrotic therapy

site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com